Navigation Links
Medolac Hires Doug Hawkins as Senior Executive

LAKE OSWEGO, Ore., Sept. 30, 2013 /PRNewswire-iReach/ -- Medolac Laboratories (Neolac, Inc. dba), today announced the hiring of J. Douglas Hawkins as the company's Senior Vice President of Corporate Affairs. This new position was created to drive Medolac's corporate development efforts globally. Mr. Hawkins will be reporting directly to Medolac's founder, president and CEO, Elena Medo.            

As the SVP of Corporate Affairs, Mr. Hawkins will be responsible for managing efforts to maximize Medolac's impact in global markets, including identifying and developing partnership, alliance and cooperative agreements with key corporate, government, hospital, international organizations and non-governmental organization (NGO) stakeholders.  He also will be responsible for global public affairs and issues management.

In discussing Mr. Hawkins' appointment, Ms. Medo said, "We are extremely pleased that Doug is joining Medolac at such a critical point in our development.  He brings a wealth of experience in developing global nutritional and pediatric vaccine assets. His corporate responsibility acumen, including a long history of forging successful public/private partnerships will be critical to our success.  His leadership will provide a strategic, values-driven and sustainable approach to expand our product reach worldwide.  

 "I am delighted to join Medolac.  Their innovative and ethical approach will greatly improve health outcomes for the most vulnerable among us, premature infants", stated Doug Hawkins. "The immense life-saving potential  and the health economics of human milk adapted therapies are unrivaled, representing an unprecedented opportunity to reduce infant morbidity and mortality at this early life stage."       

Mr Hawkins, 47, comes to Medolac from Pfizer/Wyeth Nutrition where he served as Vice President of Public Affairs and Policy for several years.  During his tenure, Mr. Hawkins was responsible for overseeing corporate and government affairs at HQ and in key markets, including teams in several important South East Asia, greater China, Middle East and Latin America regions. He led successful efforts to implement Pfizer's responsible marketing commitments in a challenging compliance environment, led collaborative initiatives that positioned Pfizer Nutrition favorably amongst its peers, and successfully managed high profile issues affecting the business across the world. He also brings a wealth of experience from the multilateral public sector, having worked for more than  a decade leading Treaty operations activities at the United Nations agency responsible for intellectual property in Geneva, Switzerland.  He has chaired several committees including the PhRMA industry committee on global issues and served on various boards including the advisory board of the GW Law School Creative and Innovative Economy Center.  

About Medolac:

Medolac Laboratories ( is a Delaware corporation (Neolac Inc. dba Medolac) headquartered at Lake Oswego, Oregon in the Pacific Northwest of the United States. Our vision is to provide human milk based therapies to critically ill babies and children on a global basis by applying proprietary biopharmaceutical processing methods that preserve the immune components in human milk while providing the safest, highest quality human milk formulations available to babies in need. 

Media Contact: Yvonne Arroyo, Medolac Laboratories, 8665997740,

News distributed by PR Newswire iReach:

SOURCE Medolac Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Spectrum Orthotics And Prosthetics Hires New Practitioner
2. SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
3. BioSante Hires VP of New Business Development and Contract Manufacturing and Announces New Appointment to Board of Directors
4. Tris Pharma Hires President for Generic Pharmaceuticals Business
5. United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services
6. Swisse Wellness Australia Hires MWW As Public Relations Agency Of Record For U.S. Launch
7. Assured Pharmacy Hires Hayden IR
8. Tribogenics Expands X-Ray Development Team With Key Hires
9. Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
10. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
11. ChanTest hires Chris Mathes as Chief Commercial Officer
Post Your Comments:
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ( ... Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac ... " report to their offering. ... Boston scientific and others. --> ... Medtronic, Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
(Date:11/26/2015)... , November 26, 2015 ... the "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... report to their offering. --> Research ... addition of the "Self Administration of High ...
Breaking Medicine Technology:
(Date:11/27/2015)... Francisco, California (PRWEB) , ... November 27, 2015 , ... ... Janis Joplin Ann Arbor Michigan boxing style concert posters. This is one of Joplin's ... at the Canterbury House at the University of Michigan in Ann Arbor. The According ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... substance abuse located in central Michigan, have come together on Thanksgiving Day to ... produced video, available for viewing on the Serenity Point YouTube channel, patients displayed ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... a real-time eReferral system for diagnostic imaging in the Waterloo region. Using the ... and Nuclear Medicine tests directly from their electronic medical record (EMR) without the ...
(Date:11/26/2015)... ... , ... The Catalent Applied Drug Delivery Institute today announced ... form selection in early phase drug development. The first of these is to ... the UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating their record ... performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment for the ... to rebuild lives and it’s an honor to have served all of these women.” ...
Breaking Medicine News(10 mins):